FI823021L - Produkter, medelst vilka antigeniteten hos hepatitis b virus e antigener kan bestaemmas och foerfaranden foer framstaellning av dessa antigener - Google Patents

Produkter, medelst vilka antigeniteten hos hepatitis b virus e antigener kan bestaemmas och foerfaranden foer framstaellning av dessa antigener

Info

Publication number
FI823021L
FI823021L FI823021A FI823021A FI823021L FI 823021 L FI823021 L FI 823021L FI 823021 A FI823021 A FI 823021A FI 823021 A FI823021 A FI 823021A FI 823021 L FI823021 L FI 823021L
Authority
FI
Finland
Prior art keywords
antigener
bestaemmas
antigeniteten
medelst
produkter
Prior art date
Application number
FI823021A
Other languages
English (en)
Finnish (fi)
Other versions
FI823021A0 (fi
Inventor
Kenneth Murray
Patricia Mackay
Original Assignee
Biogen Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogen Nv filed Critical Biogen Nv
Publication of FI823021A0 publication Critical patent/FI823021A0/fi
Publication of FI823021L publication Critical patent/FI823021L/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5761—Hepatitis B
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/81—Packaged device or kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/848—Escherichia
    • Y10S435/849—Escherichia coli
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/81—Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/825—Bacteria
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/826—Viruses
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/22—Viral peptide or viral protein
    • Y10S930/223—Hepatitis related
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/31—Linker sequence

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Food Science & Technology (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
FI823021A 1981-09-02 1982-09-01 Produkter, medelst vilka antigeniteten hos hepatitis b virus e antigener kan bestaemmas och foerfaranden foer framstaellning av dessa antigener FI823021L (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8126583 1981-09-02

Publications (2)

Publication Number Publication Date
FI823021A0 FI823021A0 (fi) 1982-09-01
FI823021L true FI823021L (fi) 1983-03-03

Family

ID=10524270

Family Applications (1)

Application Number Title Priority Date Filing Date
FI823021A FI823021L (fi) 1981-09-02 1982-09-01 Produkter, medelst vilka antigeniteten hos hepatitis b virus e antigener kan bestaemmas och foerfaranden foer framstaellning av dessa antigener

Country Status (9)

Country Link
US (2) US4563423A (fr)
EP (1) EP0075395A3 (fr)
JP (3) JPS5852228A (fr)
AU (1) AU8746582A (fr)
CA (1) CA1209502A (fr)
DK (1) DK389682A (fr)
ES (1) ES515418A0 (fr)
FI (1) FI823021L (fr)
ZA (1) ZA826310B (fr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8321789D0 (en) * 1983-08-12 1983-09-14 Biogen Nv Vaccines and compositions against hepatitis
US4722891A (en) * 1984-06-20 1988-02-02 Board Of Regents, The University Of Texas System Methods and compositions for detection of Legionnaires' disease
JPS6137738A (ja) * 1984-07-31 1986-02-22 Tetsuo Nakamura Ｂ型肝炎ワクチン
JPS61103895A (ja) * 1984-10-26 1986-05-22 Green Cross Corp:The ＨＢｓＡｇの精製方法
JPS61233700A (ja) * 1984-12-24 1986-10-17 ジエネンテク，インコ−ポレイテツド 分子クロ−ンされたエイズ関連ポリペプチド
US6534285B1 (en) 1984-12-24 2003-03-18 Genentech, Inc. Molecularly cloned acquired immunodeficiency syndrome polypeptides and their methods of use
US5853978A (en) * 1985-12-04 1998-12-29 Genentech, Inc. Molecularly cloned acquired immunodeficiency syndrome polypeptides and methods of use
EP0232410A4 (fr) * 1985-08-15 1988-01-25 Amgen Procede et tampon de lyse pour l'extraction d'un antigene de surface de l'hepatite b a partir de cellules de levure.
JPH084507B2 (ja) * 1985-10-03 1996-01-24 武田薬品工業株式会社 新規ｄｎａおよびポリペプチド
EP0272483A1 (fr) * 1986-12-19 1988-06-29 Abbott Laboratories Méthodes et moyens pour la production d'HBeAg
ATE207535T1 (de) * 1987-06-22 2001-11-15 Medeva Holdings Bv Hepatitis-b-oberflächenantigen enthaltendes peptid
EP0311228A3 (fr) * 1987-10-09 1990-05-02 Repligen Corporation Polypeptides recombinants et leur utilisation, y compris un diagnostic pour le virus du SIDA
DE68907996T2 (de) * 1988-05-11 1994-01-05 Abbott Lab Verfahren zur Erhöhung der Spezifizität in kompetitiven Immuntests.
US5122449A (en) * 1988-10-07 1992-06-16 Eastman Kodak Company Use of a protease in the extraction of chlamydial, gonococcal and herpes antigens
WO1990008960A1 (fr) * 1989-02-06 1990-08-09 Imclone Systems, Inc. Antigene d'hepatite e stabilise adapte pour des analyses immunologiques
US5501948A (en) * 1989-02-06 1996-03-26 Imclone Systems Incorporated Stabilized hepatitis B e antigen suitable for immunoassays
EP0491077A1 (fr) * 1990-12-19 1992-06-24 Medeva Holdings B.V. Composition utilisée comme agent thérapeutique contre des maladies hépatiques chroniques
DE4107612A1 (de) 1991-03-09 1992-09-10 Behringwerke Ag Rekombinante proteine mit der immunreaktivitaet des hepatitis b virus e antigens (hbeag), verfahren zu ihrer herstellung und ihre verwendung in immunoassays und impfstoffen
JP3225468B2 (ja) * 1992-08-28 2001-11-05 ダイナボット株式会社 抗体測定用試薬
CA2250076A1 (fr) * 1996-03-19 1997-09-25 Akzo Nobel Nv Procede de pronostic de l'evolution d'une hepatite b
US6887464B1 (en) 1999-02-02 2005-05-03 Biocache Pharmaceuticals, Inc. Advanced antigen presentation platform
ES2374812T3 (es) * 2000-08-11 2012-02-22 Advanced Life Science Institute, Inc. Método para detectar o medir vhb.
WO2002016947A2 (fr) * 2000-08-21 2002-02-28 Queen's University At Kingston Procedes et trousses pour la separation et la detection de proteines dans des echantillons biologiques

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3636191A (en) * 1969-10-08 1972-01-18 Cancer Res Inst Vaccine against viral hepatitis and process
BE796781A (nl) * 1973-03-15 1973-09-17 Den Bosch Maurits R M J Van Verbeterde armband of dergelijke
JPS50312A (fr) * 1973-05-09 1975-01-06
US4164565A (en) * 1975-03-14 1979-08-14 New York Blood Center, Inc. Vaccine for active immunization containing hepatitis B surface antigen and associated antigen
FR2303562A1 (fr) * 1975-03-14 1976-10-08 Community Blood Council Greate Nouvelle preparation d'antigene utilisable comme vaccin
US4017360A (en) * 1975-05-14 1977-04-12 Merck & Co., Inc. Method for purifying hepatitis B antigen
US4021540A (en) * 1975-07-28 1977-05-03 Ortho Diagnostics Inc. Preparation of a hepatitis B immune globulin and use thereof as a prophylactic material
SE420977B (sv) * 1976-03-18 1981-11-16 Kabi Ab Forfarande for rening och isolering av hepatitvirus for vaccinframstellning
US4102996A (en) * 1977-04-20 1978-07-25 Merck & Co., Inc. Method of preparing hepatitis B core antigen
FR2398504A1 (fr) * 1977-07-29 1979-02-23 Tours Inst Virologie Culture de virus de l'hepatite a, in vitro. application a la production d'un antigene reactif, d'immunserums specifiques et de vaccins contre l'hepatite a
US4197361A (en) * 1977-08-23 1980-04-08 Warner-Lambert Fluorescent immunoassay sandwich technique for HBs Ag
US4234564A (en) * 1977-12-19 1980-11-18 Merck & Co., Inc. Hepatitis B core antigen composition
FR2422685A1 (fr) * 1978-04-14 1979-11-09 Pasteur Institut Vecteurs, derives du bacteriophage lambda, permettant l'insertion et l'expression d'un gene, procaryote ou eucaryote, sous le controle du promoteur et de l'operateur de l'operon lactose de la bacterie escherichia coli
ZA792485B (en) * 1978-06-07 1980-06-25 New York Blood Center Inc Vaccine for active immunization containing hepatitis b surface and/or e-antigens
US4164566A (en) * 1978-08-17 1979-08-14 Merck & Co., Inc. Hepatitis a virus cell culture in vitro
US4162192A (en) * 1978-09-28 1979-07-24 Juridical Foundation Method for purification of HBs antigen
US4204989A (en) * 1978-12-13 1980-05-27 Merck & Co., Inc. Isolation of hepatitis B e antigen
FR2444713A1 (fr) * 1978-12-18 1980-07-18 Pasteur Institut Procede de production d'un adn comprenant le genome du virus de l'hepatite b et vecteur le comportant
ES487106A0 (es) * 1978-12-22 1981-05-16 Biogen Nv Un metodo para producir al menos un polipeptido que muestra antigenicidad de hbv
US4301250A (en) * 1979-11-02 1981-11-17 Merck & Co., Inc. Method of producing hepatitis B surface antigen
US4617260A (en) * 1981-02-27 1986-10-14 Merck & Co., Inc. RIA assay for HBcAg

Also Published As

Publication number Publication date
ES8404186A1 (es) 1984-04-16
FI823021A0 (fi) 1982-09-01
EP0075395A2 (fr) 1983-03-30
JPH06194369A (ja) 1994-07-15
ZA826310B (en) 1983-07-27
JPH06194368A (ja) 1994-07-15
DK389682A (da) 1983-03-03
JPS5852228A (ja) 1983-03-28
CA1209502A (fr) 1986-08-12
EP0075395A3 (fr) 1984-03-07
US4563423A (en) 1986-01-07
ES515418A0 (es) 1984-04-16
AU8746582A (en) 1983-03-10
US4758507A (en) 1988-07-19

Similar Documents

Publication Publication Date Title
FI823021L (fi) Produkter, medelst vilka antigeniteten hos hepatitis b virus e antigener kan bestaemmas och foerfaranden foer framstaellning av dessa antigener
FI880428A (fi) Ytantigener av hepatit b virus och hybridantigener innehaollande desamma.
FI850468A0 (fi) Styrsystem foer motorgeneratorenhet och foerfarande foer styrning av funktionen hos en motorgeneratorenhet.
FI821451A0 (fi) Foerfaranden, anordningar och produkter foer optiska fibersystem
FI873357A (fi) Foerfarande foer bekaempning av loppor hos hundar och katter.
FI902392A0 (fi) Foerfarande och anordning foer uttagning av res ur fisk.
FI900433A0 (fi) Foerfarande och anordning foer reglering av profiljaemnheten hos en materialbana.
FI821962A0 (fi) Mandelsyraderivat och mandelonitriler, foerfaranden foer deras framstaellning och deras anvaendning bekaempning av mikro-organismer
FI824109A0 (fi) Glasblandningar, produkter och tilverkningsfoerfarande av naturliga zeoliter
FI860648A (fi) Foerfarande och anordning foer bestaemning av vattenhalten hos oljebaserade och liknande vaetskor.
FI842636A0 (fi) Foerfarande och anordning foer registrering av foeraendringar hos variabler.
FI882232A0 (fi) Anordning och foerfarande foer bestaemmande av hastigheten hos fordon.
FI830534L (fi) Saett och anordning foer bestaemning av egenskaperna hos en fibermassa.
FI871638A0 (fi) Foerfarande foer foerbaettrande av jaemngaongen hos en slagkolvfoerbraenningsmotormaskin och slagkolvfoerbraenningsmotormaskin foer utoevande av foerfarandet.
FI842313A0 (fi) Foerfarande foer maetning och reglering av paofyllningsnivaon hos i en behaollare belaeget aemne.
FI903561A0 (fi) Foerfarande foer framstaellning av hydrolyserade vaextproteiner och med hjaelp av detta erhaollna produkter.
FI823910L (fi) Azolyl-penten-derivat, foerfaranden foer framstaellning av dessa foereningar och dessa innehaollandbiocider
FI824135L (fi) Foerfarande foer separering av blandningar av insulin, insulinderivat och eventuella foeroreningar
FI854916A (fi) Foerfarande och anordning foer minskning hoegfrekvent elenergi av fuktighetsdifferenserna hos en roerlig bana medelst.
FI901942A0 (fi) Foerfarande foer faergning av ytan hos metallmaterial och genom detta erhaollna produkter.
FI842434A0 (fi) Anordning foer sammankoppling av vertikala och horisontella element.
FI844371A0 (fi) Foerfarande och foerening foer reglerande av tillvaexten hos vaexter.
FI893360A0 (fi) Foerfarande och anordning foer reglering av bladprofilen hos en bladschaber.
FI861164A0 (fi) Anordning foer flyttning och tipping av bytbar flak.
FI863960A0 (fi) Anordning foer flyttning och tipping av bytbart flak.

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: BIOGEN N.V.